We performed a retrospective screening of 428 serum samples for anti-SARS-CoV-2 immunoglobulin during a period of low prevalence. Employing two different serological tests yielded discrepant results for 10 samples; highlighting an increased risk of potential false positive results and the need for further confirmatory testing before publication of data.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968146 | PMC |
| http://dx.doi.org/10.1016/j.jinf.2021.03.007 | DOI Listing |
Publication Analysis
Top Keywords
low prevalence
8
retrospective serosurveillance
4
serosurveillance anti-sars-cov-2
4
anti-sars-cov-2 immunoglobulin
4
immunoglobulin time
4
time low
4
prevalence cautionary
4
cautionary tale
4
tale performed
4
performed retrospective
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!